. 2021 Aug 23;36(1):1922–1930. doi: 10.1080/14756366.2021.1969385
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 1.
Example of currently used antileishmanial therapeutic agents.